ATHEROTHROMBOTIC RISK STRATIFICATION AND EZETIMIBE USE IN IMPROVE-IT
2016
Pts with
acute coronary syndrome(ACS) vary in their risk for recurrent CV events.
Ezetimibe(EZ) is safe and effective for 2° prevention with an overall 10% relative reduction in CV death, myocardial infarction or ischemic stroke (CVD/MI/iCVA). Risk assessment may be useful to identify pts who
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI